Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties
- PMID: 15804517
- DOI: 10.1016/j.toxicon.2004.12.024
Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties
Abstract
Trichosanthin (TCS), a ribosome-inactivating protein extracted from the root tuber of Chinese medicinal herb Trichosanthes kirilowii Maximowicz, has multiple pharmacological properties including abortifacient, anti-tumor and anti-HIV. It is traditionally used to induce abortion but its antigenicity and short plasma half-life have limited the repeated clinical administration. In this review, work to locating antigenic sites and prolonging plasma half-life are discussed. Studies on structure-function relationship and mechanism of cell entry are also covered. Recently, TCS has been found to induce apoptosis, enhance the action of chemokines and inhibit HIV-1 integrase. These findings give new insights on the pharmacological properties of TCS and other members of ribosome-inactivating proteins.
Similar articles
-
Possible mechanisms of trichosanthin-induced apoptosis of tumor cells.Anat Rec (Hoboken). 2010 Jun;293(6):986-92. doi: 10.1002/ar.21142. Anat Rec (Hoboken). 2010. PMID: 20225201 Review.
-
Minireview: trichosanthin--a protein with multiple pharmacological properties.Life Sci. 1994;55(4):253-62. doi: 10.1016/0024-3205(94)00727-6. Life Sci. 1994. PMID: 8028444 Review.
-
Effect of site-directed PEGylation of trichosanthin on its biological activity, immunogenicity, and pharmacokinetics.Biomol Eng. 2007 Dec;24(6):643-9. doi: 10.1016/j.bioeng.2007.10.002. Epub 2007 Oct 23. Biomol Eng. 2007. PMID: 18023612
-
Anti-HIV agent trichosanthin enhances the capabilities of chemokines to stimulate chemotaxis and G protein activation, and this is mediated through interaction of trichosanthin and chemokine receptors.J Exp Med. 1999 Jul 5;190(1):101-11. doi: 10.1084/jem.190.1.101. J Exp Med. 1999. PMID: 10429674 Free PMC article.
-
Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro.Biochem Biophys Res Commun. 2004 May 14;317(4):965-71. doi: 10.1016/j.bbrc.2004.03.139. Biochem Biophys Res Commun. 2004. PMID: 15094363
Cited by
-
Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review.Cancer Chemother Pharmacol. 2013 Jun;71(6):1387-93. doi: 10.1007/s00280-013-2096-y. Epub 2013 Feb 3. Cancer Chemother Pharmacol. 2013. PMID: 23377374 Free PMC article. Review.
-
Structure-function study of maize ribosome-inactivating protein: implications for the internal inactivation region and the sole glutamate in the active site.Nucleic Acids Res. 2007;35(18):6259-67. doi: 10.1093/nar/gkm687. Epub 2007 Sep 13. Nucleic Acids Res. 2007. PMID: 17855394 Free PMC article.
-
Genetically-engineered "all-in-one" vaccine platform for cancer immunotherapy.Acta Pharm Sin B. 2021 Nov;11(11):3622-3635. doi: 10.1016/j.apsb.2021.06.001. Epub 2021 Jun 8. Acta Pharm Sin B. 2021. PMID: 34900541 Free PMC article.
-
The C-terminal fragment of the ribosomal P protein complexed to trichosanthin reveals the interaction between the ribosome-inactivating protein and the ribosome.Nucleic Acids Res. 2009 Feb;37(2):602-10. doi: 10.1093/nar/gkn922. Epub 2008 Dec 10. Nucleic Acids Res. 2009. PMID: 19073700 Free PMC article.
-
AtIQM1, a novel calmodulin-binding protein, is involved in stomatal movement in Arabidopsis.Plant Mol Biol. 2012 Jul;79(4-5):333-46. doi: 10.1007/s11103-012-9915-0. Epub 2012 May 10. Plant Mol Biol. 2012. PMID: 22572939
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical